Switch to Dark

Pricing

Learn

ISRG - Intuitive Surgical Inc

438

$477.73

-$5.03 (-1.042%)

At market close

$477.06

-$0.67 (-0.140%)

After Hours 3/18/26, 10:27 PM

Score

3.74/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

ISRG

Valuation Score

View as %

Stock Unlock

YTD

Max

Key Data & Metrics

Market Cap

$169.66B

Industry

Health Care

EPS (TTM)

$7.92

P/E (TTM)

59.40

Div & Yield

FCF Payout Ratio

P/S (TTM)

16.86

P/B

9.52

Diluted Shares

360.30M

Ex-Dividend

Next Earnings

04-20

Forward P/E

48.30

Payout Ratio

P/FCF (TTM)

68.12

FCF Yield

1.47%

Earnings Yield

1.68%

52 Week Range

Score Card

Explore Scores Tab

3.74

Good

Intuitive Surgical Inc has grown revenue at 20.51% over the past year, which is strong growth. Also, it has more cash than liabilities meaning it could use its current cash position to be completely debt-free, if it wanted to.

Valuation Model

Key Score

5.00

Very Good

Management

2.00

Bad

Growth

1.00

Very Bad

Profitability

3.00

Average

Fin. Health

1.00

Very Bad

Dividends

Analyst

5.00

Very Good

Insider Transactions

Explore Insider Tab

Buy

Sell

Market News

Page 1 of 21

3 new filings were in the last 7 days

Filter Form Types

Form DEFA14A

Additional definitive proxy soliciting materials

Filed on 2026-03-13 17:22:51

Form ARS

Unknown Form Type

Filed on 2026-03-13 17:21:07

Form DEF 14A

Also known as a 'definitive proxy statement', is a required filing when a shareholder vote is required

Filed on 2026-03-13 17:16:52

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-11 13:46:06

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-03-10 16:47:55

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-10 14:24:12

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-05 18:38:35

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-03-05 16:43:21

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-03-04 16:43:23

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-03 18:17:13

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-03 17:34:38

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-03-03 16:32:19

Page 1 of 21

Financials

Explore Financials Tab

Revenue

Earnings

Free Cash Flow

Price Targets

Go to Analyst Tab

These are one year price targets for: 2027-02-21

High:

$787.50

64.8%

Avg:

$624.51

30.7%

Low:

$444.40

-7.0%

(% change is relative to the current stock price: $477.73)

Analyst Recommendations

Go to Analyst Tab

3.90

Good

24%

Strong Buy (10)

45%

Buy (19)

29%

Hold (12)

Sell (1)

Strong Sell (0)

About

Website
https://www.intuitive.com/en-us/about-us/company
Address
1020 Kifer Road, Sunnyvale CALIFORNIA, US
SEC Reports
https://sec.gov/edgar/browse/?CIK=1035267

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California and currently employs 17,021 full-time employees. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.

IPO Date

2000-06-13

Industry

Health Care

Total Employees

15,638

Exchange

Nasdaq Nms - Global Market

Reporting Currency

USD

GICS

Health Care Equipment & Supplies

GICS Sub

Health Care Equipment

GICS Sector

Health Care

GICS Group

Health Care Equipment & Services

Switch to Dark

Pricing

Learn

ISRG - Intuitive Surgical Inc

438

$477.73

-$5.03 (-1.042%)

$477.06

-$0.67 (-0.140%)

3.74/5

Stock Unlock

Key Data & Metrics

Score Card

Good

Insider Transactions

Market News

Form DEFA14A

Filed on 2026-03-13 17:22:51

Form ARS

Filed on 2026-03-13 17:21:07

Form DEF 14A

Filed on 2026-03-13 17:16:52

Form 4

Filed on 2026-03-11 13:46:06

Form 144

Filed on 2026-03-10 16:47:55

Form 4

Filed on 2026-03-10 14:24:12

Form 4

Filed on 2026-03-05 18:38:35

Form 144

Filed on 2026-03-05 16:43:21

Form 144

Filed on 2026-03-04 16:43:23

Form 4

Filed on 2026-03-03 18:17:13

Form 4

Filed on 2026-03-03 17:34:38

Form 144

Filed on 2026-03-03 16:32:19

Financials

Price Targets

64.8%

30.7%

-7.0%

Analyst Recommendations

About

Similar Stocks